Structural insights into catalytical capability for CPT11 hydrolysis and substrate specificity of a novel marine microbial carboxylesterase, E93
CPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer prodrug. The activation of its warhead, SN38 (7-ethyl-10-hydroxycamptothecin), requires hydrolysis by carboxylesterases. NPC (7-ethyl-10-[4-(1-piperidin...
Saved in:
Published in | Frontiers in microbiology Vol. 13; p. 1081094 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
11.01.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 1664-302X 1664-302X |
DOI | 10.3389/fmicb.2022.1081094 |
Cover
Loading…
Abstract | CPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer prodrug. The activation of its warhead, SN38 (7-ethyl-10-hydroxycamptothecin), requires hydrolysis by carboxylesterases. NPC (7-ethyl-10-[4-(1-piperidino)-1-amino] carbonyloxycamptothecin) is a metabolic derivative of CPT11 and is difficult to be hydrolyzed by human carboxylesterase. Microbial carboxylesterase with capability on both CPT11 and NPC hydrolysis is rarely reported. A marine microbial carboxylesterase, E93, was identified to hydrolyze both substrates in this study. This enzyme was an appropriate subject for uncovering the catalytic mechanism of carboxylesterases to CPT11 and NPC hydrolysis.
X-ray diffraction method was applied to obtain high-resolution structure of E93. Molecular docking was adopted to analyze the interaction of E93 with
-NP (
-nitrophenyl), CPT11, and NPC substrates. Mutagenesis and enzymatic assay were adopted to verify the binding pattern of substrates.
Three core regions (Region A, B, and C) of the catalytic pocket were identified and their functions on substrates specificity were validated
mutagenesis assays. The Region A was involved in the binding with the alcohol group of all tested substrates. The size and hydrophobicity of the region determined the binding affinity. The Region B accommodated the acyl group of
-NP and CPT11 substrates. The polarity of this region determined the catalytic preference to both substrates. The Region C specifically accommodated the acyl group of NPC. The interaction from the acidic residue, E428, contributed to the binding of E93 with NPC.
The study analyzed both unique and conserved structures of the pocket in E93, for the first time demonstrating the discrepancy of substrate-enzyme interaction between CPT11 and NPC. It also expanded the knowledge about the substrate specificity and potential application of microbial Family VII carboxylesterases. |
---|---|
AbstractList | CPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer prodrug. The activation of its warhead, SN38 (7-ethyl-10-hydroxycamptothecin), requires hydrolysis by carboxylesterases. NPC (7-ethyl-10-[4-(1-piperidino)-1-amino] carbonyloxycamptothecin) is a metabolic derivative of CPT11 and is difficult to be hydrolyzed by human carboxylesterase. Microbial carboxylesterase with capability on both CPT11 and NPC hydrolysis is rarely reported. A marine microbial carboxylesterase, E93, was identified to hydrolyze both substrates in this study. This enzyme was an appropriate subject for uncovering the catalytic mechanism of carboxylesterases to CPT11 and NPC hydrolysis.
X-ray diffraction method was applied to obtain high-resolution structure of E93. Molecular docking was adopted to analyze the interaction of E93 with
-NP (
-nitrophenyl), CPT11, and NPC substrates. Mutagenesis and enzymatic assay were adopted to verify the binding pattern of substrates.
Three core regions (Region A, B, and C) of the catalytic pocket were identified and their functions on substrates specificity were validated
mutagenesis assays. The Region A was involved in the binding with the alcohol group of all tested substrates. The size and hydrophobicity of the region determined the binding affinity. The Region B accommodated the acyl group of
-NP and CPT11 substrates. The polarity of this region determined the catalytic preference to both substrates. The Region C specifically accommodated the acyl group of NPC. The interaction from the acidic residue, E428, contributed to the binding of E93 with NPC.
The study analyzed both unique and conserved structures of the pocket in E93, for the first time demonstrating the discrepancy of substrate-enzyme interaction between CPT11 and NPC. It also expanded the knowledge about the substrate specificity and potential application of microbial Family VII carboxylesterases. IntroductionCPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer prodrug. The activation of its warhead, SN38 (7-ethyl-10-hydroxycamptothecin), requires hydrolysis by carboxylesterases. NPC (7-ethyl-10-[4-(1-piperidino)-1-amino] carbonyloxycamptothecin) is a metabolic derivative of CPT11 and is difficult to be hydrolyzed by human carboxylesterase. Microbial carboxylesterase with capability on both CPT11 and NPC hydrolysis is rarely reported. A marine microbial carboxylesterase, E93, was identified to hydrolyze both substrates in this study. This enzyme was an appropriate subject for uncovering the catalytic mechanism of carboxylesterases to CPT11 and NPC hydrolysis.MethodsX-ray diffraction method was applied to obtain high-resolution structure of E93. Molecular docking was adopted to analyze the interaction of E93 with p-NP (p-nitrophenyl), CPT11, and NPC substrates. Mutagenesis and enzymatic assay were adopted to verify the binding pattern of substrates.ResultsThree core regions (Region A, B, and C) of the catalytic pocket were identified and their functions on substrates specificity were validated via mutagenesis assays. The Region A was involved in the binding with the alcohol group of all tested substrates. The size and hydrophobicity of the region determined the binding affinity. The Region B accommodated the acyl group of p-NP and CPT11 substrates. The polarity of this region determined the catalytic preference to both substrates. The Region C specifically accommodated the acyl group of NPC. The interaction from the acidic residue, E428, contributed to the binding of E93 with NPC.DiscussionThe study analyzed both unique and conserved structures of the pocket in E93, for the first time demonstrating the discrepancy of substrate-enzyme interaction between CPT11 and NPC. It also expanded the knowledge about the substrate specificity and potential application of microbial Family VII carboxylesterases. CPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer prodrug. The activation of its warhead, SN38 (7-ethyl-10-hydroxycamptothecin), requires hydrolysis by carboxylesterases. NPC (7-ethyl-10-[4-(1-piperidino)-1-amino] carbonyloxycamptothecin) is a metabolic derivative of CPT11 and is difficult to be hydrolyzed by human carboxylesterase. Microbial carboxylesterase with capability on both CPT11 and NPC hydrolysis is rarely reported. A marine microbial carboxylesterase, E93, was identified to hydrolyze both substrates in this study. This enzyme was an appropriate subject for uncovering the catalytic mechanism of carboxylesterases to CPT11 and NPC hydrolysis.IntroductionCPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer prodrug. The activation of its warhead, SN38 (7-ethyl-10-hydroxycamptothecin), requires hydrolysis by carboxylesterases. NPC (7-ethyl-10-[4-(1-piperidino)-1-amino] carbonyloxycamptothecin) is a metabolic derivative of CPT11 and is difficult to be hydrolyzed by human carboxylesterase. Microbial carboxylesterase with capability on both CPT11 and NPC hydrolysis is rarely reported. A marine microbial carboxylesterase, E93, was identified to hydrolyze both substrates in this study. This enzyme was an appropriate subject for uncovering the catalytic mechanism of carboxylesterases to CPT11 and NPC hydrolysis.X-ray diffraction method was applied to obtain high-resolution structure of E93. Molecular docking was adopted to analyze the interaction of E93 with p-NP (p-nitrophenyl), CPT11, and NPC substrates. Mutagenesis and enzymatic assay were adopted to verify the binding pattern of substrates.MethodsX-ray diffraction method was applied to obtain high-resolution structure of E93. Molecular docking was adopted to analyze the interaction of E93 with p-NP (p-nitrophenyl), CPT11, and NPC substrates. Mutagenesis and enzymatic assay were adopted to verify the binding pattern of substrates.Three core regions (Region A, B, and C) of the catalytic pocket were identified and their functions on substrates specificity were validated via mutagenesis assays. The Region A was involved in the binding with the alcohol group of all tested substrates. The size and hydrophobicity of the region determined the binding affinity. The Region B accommodated the acyl group of p-NP and CPT11 substrates. The polarity of this region determined the catalytic preference to both substrates. The Region C specifically accommodated the acyl group of NPC. The interaction from the acidic residue, E428, contributed to the binding of E93 with NPC.ResultsThree core regions (Region A, B, and C) of the catalytic pocket were identified and their functions on substrates specificity were validated via mutagenesis assays. The Region A was involved in the binding with the alcohol group of all tested substrates. The size and hydrophobicity of the region determined the binding affinity. The Region B accommodated the acyl group of p-NP and CPT11 substrates. The polarity of this region determined the catalytic preference to both substrates. The Region C specifically accommodated the acyl group of NPC. The interaction from the acidic residue, E428, contributed to the binding of E93 with NPC.The study analyzed both unique and conserved structures of the pocket in E93, for the first time demonstrating the discrepancy of substrate-enzyme interaction between CPT11 and NPC. It also expanded the knowledge about the substrate specificity and potential application of microbial Family VII carboxylesterases.DiscussionThe study analyzed both unique and conserved structures of the pocket in E93, for the first time demonstrating the discrepancy of substrate-enzyme interaction between CPT11 and NPC. It also expanded the knowledge about the substrate specificity and potential application of microbial Family VII carboxylesterases. |
Author | Rong, Zhen Li, Jixi Xu, Xue-Wei Li, Yang Cui, Henglin Li, Zhengyang |
AuthorAffiliation | 1 School of Oceanography, Zhejiang University , Zhoushan , China 4 School of Food and Biological Engineering, Jiangsu University , Zhenjiang , China 3 State Key Laboratory of Genetic Engineering, School of Life Sciences, Shanghai Engineering Research Center of Industrial Microorganisms, Fudan University , Shanghai , China 2 Key Laboratory of Marine Ecosystem Dynamics, Ministry of Natural Resources and Second Institute of Oceanography, Ministry of Natural Resources , Hangzhou , China |
AuthorAffiliation_xml | – name: 1 School of Oceanography, Zhejiang University , Zhoushan , China – name: 3 State Key Laboratory of Genetic Engineering, School of Life Sciences, Shanghai Engineering Research Center of Industrial Microorganisms, Fudan University , Shanghai , China – name: 2 Key Laboratory of Marine Ecosystem Dynamics, Ministry of Natural Resources and Second Institute of Oceanography, Ministry of Natural Resources , Hangzhou , China – name: 4 School of Food and Biological Engineering, Jiangsu University , Zhenjiang , China |
Author_xml | – sequence: 1 givenname: Yang surname: Li fullname: Li, Yang – sequence: 2 givenname: Zhen surname: Rong fullname: Rong, Zhen – sequence: 3 givenname: Zhengyang surname: Li fullname: Li, Zhengyang – sequence: 4 givenname: Henglin surname: Cui fullname: Cui, Henglin – sequence: 5 givenname: Jixi surname: Li fullname: Li, Jixi – sequence: 6 givenname: Xue-Wei surname: Xu fullname: Xu, Xue-Wei |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36756200$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uk1vEzEQXaEiWkr_AAfkIwcS_LXe9QUJRQUqVQKJHLhZY683ceWsg-2t2H_BT8abhKrlgA_2yPPmzfP4vazOhjDYqnpN8JKxVr7vd87oJcWULgluCZb8WXVBhOALhumPs0fxeXWV0h0ui2Na9hfVORNNLUp8Uf3-nuNo8hjBIzckt9nmVIIckIEMfsrOlIyBPWjnXZ5QHyJafVsTgrZTF4OfkksIhg6lUaccIVuU9ta43pkZHnoEaAj31qMdRDdYVHTHoN2BNerwa_I2ZRsh2XfoWrJX1fMefLJXp_OyWn-6Xq--LG6_fr5ZfbxdGC7avOAd7jEnvK-B8hr3XDYYNBOkpqQFC4LVrIWuMVYIgXXdCSZbKjW0rbYdYZfVzZG2C3Cn9tEVdZMK4NThIsSNglge763ilDZYGKM14xxjKo1oTE1ZGTm13HSF68ORaz_qne2MHcoc_BPSp5nBbdUm3CspMWnkLObtiSCGn2MZh9q5ZKz3MNgwJkWbhreSy5YV6JvHvR6a_P3RAqBHQJlyStH2DxCC1ewcdXCOmp2jTs4pRe0_ReXzILsw63X-f6V_AF2Ly_I |
CitedBy_id | crossref_primary_10_1016_j_ijbiomac_2024_137899 crossref_primary_10_1111_1751_7915_14479 |
Cites_doi | 10.1093/nar/gkq366 10.1007/s12032-019-1309-6 10.1016/j.cbi.2006.07.001 10.1016/S1359-6446(05)03383-0 10.3390/cancers11101581 10.1016/j.bcp.2005.11.020 10.1093/nar/gks1154 10.1107/S0907444904019158 10.1124/dmd.32.5.505 10.1107/S0907444909052925 10.1186/1752-153X-2-18 10.1016/j.bcp.2007.06.022 10.1517/17425247.2015.1070142 10.1002/jbt.20178 10.1124/jpet.112.201640 10.1042/0264-6021:3430177 10.2174/138955710792007196 10.1021/bi035586r 10.3390/molecules13020412 10.1038/nrc1977 10.1002/cpz1.292 10.1038/nrd2468 10.7314/apjcp 10.1099/ijs.0.057257-0 10.21873/invivo.11856 10.1107/S2059798317017557 10.1093/molbev/msw054 10.1016/j.pestbp.2020.104704 10.1021/cb800065s 10.1124/dmd.31.1.21 10.1016/j.jconrel.2013.05.005 10.1093/nar/gkq822 |
ContentType | Journal Article |
Copyright | Copyright © 2023 Li, Rong, Li, Cui, Li and Xu. Copyright © 2023 Li, Rong, Li, Cui, Li and Xu. 2023 Li, Rong, Li, Cui, Li and Xu |
Copyright_xml | – notice: Copyright © 2023 Li, Rong, Li, Cui, Li and Xu. – notice: Copyright © 2023 Li, Rong, Li, Cui, Li and Xu. 2023 Li, Rong, Li, Cui, Li and Xu |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.3389/fmicb.2022.1081094 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1664-302X |
ExternalDocumentID | oai_doaj_org_article_422706ccbb3440029c67c5230942e4cd PMC9901791 36756200 10_3389_fmicb_2022_1081094 |
Genre | Journal Article |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK ECGQY GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 PGMZT RNS RPM IAO IEA IHR IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c468t-4d0f0414f5a2450f4970ab3615218aea63538ad7ce6660b5d639829ba88bed13 |
IEDL.DBID | M48 |
ISSN | 1664-302X |
IngestDate | Wed Aug 27 01:31:53 EDT 2025 Thu Aug 21 18:38:55 EDT 2025 Fri Jul 11 07:02:56 EDT 2025 Thu Jan 02 22:54:59 EST 2025 Thu Apr 24 22:52:32 EDT 2025 Tue Jul 01 00:57:59 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | prodrug crystal structure enzyme catalysis marine bacterial carboxylesterase p-nitrophenyl substrate specificity |
Language | English |
License | Copyright © 2023 Li, Rong, Li, Cui, Li and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c468t-4d0f0414f5a2450f4970ab3615218aea63538ad7ce6660b5d639829ba88bed13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Dirk Tischler, Ruhr University Bochum, Germany; Hirokazu Suzuki, Tottori University, Japan This article was submitted to Microbiotechnology, a section of the journal Frontiers in Microbiology Edited by: Jixun Zhan, Utah State University, United States |
OpenAccessLink | https://doaj.org/article/422706ccbb3440029c67c5230942e4cd |
PMID | 36756200 |
PQID | 2774894983 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_422706ccbb3440029c67c5230942e4cd pubmedcentral_primary_oai_pubmedcentral_nih_gov_9901791 proquest_miscellaneous_2774894983 pubmed_primary_36756200 crossref_primary_10_3389_fmicb_2022_1081094 crossref_citationtrail_10_3389_fmicb_2022_1081094 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-01-11 |
PublicationDateYYYYMMDD | 2023-01-11 |
PublicationDate_xml | – month: 01 year: 2023 text: 2023-01-11 day: 11 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in microbiology |
PublicationTitleAlternate | Front Microbiol |
PublicationYear | 2023 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Hosokawa (ref12) 2008; 13 Adams (ref1) 2010; 66 Barber (ref4) 2021; 1 Gentry (ref9) 2011; 39 Fukuchi (ref8) 2020; 34 Xie (ref40) 2003; 31 Reita (ref26) 2019; 11 Wang (ref38) 2020; 170 Sanghani (ref29) 2004; 32 Palakurthi (ref21) 2015; 12 Jiang (ref16) 2008; 2 Stubdal (ref35) 2003; 63 Wierdl (ref39) 2004; 43 Zhang (ref41) 2015; 16 Lenfant (ref20) 2013; 41 Holm (ref11) 2010; 38 Ross (ref27) 2006; 71 Satoh (ref31) 2006; 162 Zhu (ref42) 2013; 344 Pommier (ref23) 2006; 6 Hough (ref13) 2018; 74 Jewell (ref15) 2007; 74 Santos (ref30) 2000; 6 Tossey (ref37) 2019; 36 Seo (ref33) 2010; 60 Emsley (ref7) 2004; 60 Lavis (ref18) 2008; 3 Schellmann (ref32) 2010; 10 Lehouritis (ref19) 2013; 170 Rautio (ref24) 2008; 7 Redinbo (ref25) 2005; 10 Arpigny (ref2) 1999; 343 Kumar (ref17) 2016; 33 Ross (ref28) 2007; 21 |
References_xml | – volume: 38 start-page: W545 year: 2010 ident: ref11 article-title: Dali server: conservation mapping in 3D publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkq366 – volume: 36 start-page: 87 year: 2019 ident: ref37 article-title: Comparison of conventional versus liposomal irinotecan in combination with fluorouracil for advanced pancreatic cancer: a single-institution experience publication-title: Med. Oncol. doi: 10.1007/s12032-019-1309-6 – volume: 162 start-page: 195 year: 2006 ident: ref31 article-title: Structure, function and regulation of carboxylesterases publication-title: Chem. Biol. Interact. doi: 10.1016/j.cbi.2006.07.001 – volume: 10 start-page: 313 year: 2005 ident: ref25 article-title: Mammalian carboxylesterases: from drug targets to protein therapeutics publication-title: Drug Discov. Today doi: 10.1016/S1359-6446(05)03383-0 – volume: 11 start-page: 1581 year: 2019 ident: ref26 article-title: Synergistic anti-tumor effect of mTOR inhibitors with irinotecan on colon cancer cells publication-title: Cancers doi: 10.3390/cancers11101581 – volume: 71 start-page: 657 year: 2006 ident: ref27 article-title: Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2005.11.020 – volume: 41 start-page: D423 year: 2013 ident: ref20 article-title: ESTHER, the database of the alpha/beta-hydrolase fold superfamily of proteins: tools to explore diversity of functions publication-title: Nucleic Acids Res. doi: 10.1093/nar/gks1154 – volume: 60 start-page: 2126 year: 2004 ident: ref7 article-title: Coot: model-building tools for molecular graphics publication-title: Acta Crystallogr. D Biol. Crystallogr. doi: 10.1107/S0907444904019158 – volume: 6 start-page: 2012 year: 2000 ident: ref30 article-title: Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans publication-title: Clin. Cancer Res. – volume: 32 start-page: 505 year: 2004 ident: ref29 article-title: Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3 publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.32.5.505 – volume: 66 start-page: 213 year: 2010 ident: ref1 article-title: PHENIX: a comprehensive Python-based system for macromolecular structure solution publication-title: Acta Crystallogr. D Biol. Crystallogr. doi: 10.1107/S0907444909052925 – volume: 2 start-page: 18 year: 2008 ident: ref16 article-title: DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0 publication-title: Chem. Cent. J. doi: 10.1186/1752-153X-2-18 – volume: 74 start-page: 932 year: 2007 ident: ref15 article-title: Inter-individual variability in esterases in human liver publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2007.06.022 – volume: 12 start-page: 1911 year: 2015 ident: ref21 article-title: Challenges in SN38 drug delivery: current success and future directions publication-title: Expert Opin. Drug Deliv. doi: 10.1517/17425247.2015.1070142 – volume: 21 start-page: 187 year: 2007 ident: ref28 article-title: Human carboxylesterases and their role in xenobiotic and endobiotic metabolism publication-title: J. Biochem. Mol. Toxicol. doi: 10.1002/jbt.20178 – volume: 344 start-page: 665 year: 2013 ident: ref42 article-title: Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.112.201640 – volume: 343 start-page: 177 year: 1999 ident: ref2 article-title: Bacterial lipolytic enzymes: classification and properties publication-title: Biochem. J. doi: 10.1042/0264-6021:3430177 – volume: 10 start-page: 887 year: 2010 ident: ref32 article-title: Targeted enzyme prodrug therapies publication-title: Mini Rev. Med. Chem. doi: 10.2174/138955710792007196 – volume: 43 start-page: 1874 year: 2004 ident: ref39 article-title: Molecular modeling of CPT-11 metabolism by carboxylesterases (CEs): use of pnbCE as a model publication-title: Biochemistry doi: 10.1021/bi035586r – volume: 13 start-page: 412 year: 2008 ident: ref12 article-title: Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs publication-title: Molecules doi: 10.3390/molecules13020412 – volume: 6 start-page: 789 year: 2006 ident: ref23 article-title: Topoisomerase I inhibitors: camptothecins and beyond publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1977 – volume: 1 start-page: e292 year: 2021 ident: ref4 article-title: Software to visualize proteins and perform structural alignments publication-title: Curr. Protoc. doi: 10.1002/cpz1.292 – volume: 7 start-page: 255 year: 2008 ident: ref24 article-title: Prodrugs: design and clinical applications publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd2468 – volume: 16 start-page: 1993 year: 2015 ident: ref41 article-title: Irinotecan as a second-line chemotherapy for small cell lung cancer: a systemic analysis publication-title: Asian Pac. J. Cancer Prev. doi: 10.7314/apjcp – volume: 60 start-page: 307 year: 2010 ident: ref33 article-title: Altererythrobacter marensis sp. nov., isolated from seawater publication-title: Int. J. Syst. Evol. Microbiol. doi: 10.1099/ijs.0.057257-0 – volume: 34 start-page: 903 year: 2020 ident: ref8 article-title: Efficacy of irinotecan as third-line chemotherapy for unresectable or recurrent gastric cancer publication-title: In Vivo doi: 10.21873/invivo.11856 – volume: 74 start-page: 67 year: 2018 ident: ref13 article-title: From crystal to structure with CCP4 publication-title: Acta Crystallogr. D Struct. Biol. doi: 10.1107/S2059798317017557 – volume: 33 start-page: 1870 year: 2016 ident: ref17 article-title: MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets publication-title: Mol. Biol. Evol. doi: 10.1093/molbev/msw054 – volume: 63 start-page: 6900 year: 2003 ident: ref35 article-title: A prodrug strategy using ONYX-015-based replicating adenoviruses to deliver rabbit carboxylesterase to tumor cells for conversion of CPT-11 to SN-38 publication-title: Cancer Res. – volume: 170 start-page: 104704 year: 2020 ident: ref38 article-title: Characterization of a novel hyper-thermostable and chlorpyrifos-hydrolyzing carboxylesterase EstC: a representative of the new esterase family XIX publication-title: Pestic. Biochem. Physiol. doi: 10.1016/j.pestbp.2020.104704 – volume: 3 start-page: 203 year: 2008 ident: ref18 article-title: Ester bonds in prodrugs publication-title: ACS Chem. Biol. doi: 10.1021/cb800065s – volume: 31 start-page: 21 year: 2003 ident: ref40 article-title: Mouse liver and kidney carboxylesterase (M-LK) rapidly hydrolyzes antitumor prodrug irinotecan and the N-terminal three quarter sequence determines substrate selectivity publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.31.1.21 – volume: 170 start-page: 120 year: 2013 ident: ref19 article-title: Bacterial-directed enzyme prodrug therapy publication-title: J. Control. Release doi: 10.1016/j.jconrel.2013.05.005 – volume: 39 start-page: 1014 year: 2011 ident: ref9 article-title: The geometry of DNA supercoils modulates the DNA cleavage activity of human topoisomerase I publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkq822 |
SSID | ssj0000402000 |
Score | 2.3416739 |
Snippet | CPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer prodrug.... IntroductionCPT11 (Irinotecan; 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) is an important camptothecin-based broad-spectrum anticancer... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1081094 |
SubjectTerms | crystal structure enzyme catalysis marine bacterial carboxylesterase Microbiology p-nitrophenyl prodrug substrate specificity |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yIPgifts7lQi-aTFJp03yqMcdhw8iuMK9lXyVW9hrj9tVrv-Ff7IzaW_ZFdEX30qbtiEzycwvmfkNY298AJtsCmV0nS0hNVAaNOxlHaVJNqoYuhxt8bk5-wafzuvznVJfFBM20QNPA_celNKiCcH7CoDOkEKjA21lWlAJQqTVF23eDpjKazDBIiGmLBlEYRbFtAwe8aBSFFYnhYU9S5QJ-__kZf4eLLljfU4fsPuz28g_TN19yO6k_hG7OxWSHB-zn18zDSxRaPBlvybAvcaLzcDz9syYN6zx-mpi5R45uqr8-MtCSn4xxush85Jw10e-xoUkE9ZyysGkOCJqPnTc8X74kVb80lG-IL9cZgan_NVrP9yMq0y5gDbxHT-x1RO2OD1ZHJ-Vc62FMkBjNiVE0QmQ0NVOQS06sFo4XzVk3o1LDv2SyrioQ0K8I3wd0bMxynpnjE9RVk_ZQT_06Tnj0ngHIWlKsgXhpEum7lKlvaySUikUTN4OextmHnIqh7FqEY-QqNosqpZE1c6iKtjb7TtXEwvHX1t_JGluWxKDdr6BetXOetX-S68K9vpWF1qccXSM4vo0fF-3ShNjD1hTFezZpBvbX1WIvxrUvILpPa3Z68v-k355kVm96YBSW3n4Pzp_xO7hgFCgXCnlC3aAOpheovO08a_yPPkFl34ZGA priority: 102 providerName: Directory of Open Access Journals |
Title | Structural insights into catalytical capability for CPT11 hydrolysis and substrate specificity of a novel marine microbial carboxylesterase, E93 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36756200 https://www.proquest.com/docview/2774894983 https://pubmed.ncbi.nlm.nih.gov/PMC9901791 https://doaj.org/article/422706ccbb3440029c67c5230942e4cd |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB9qRemL-G38KCv4ppHsZpPsPohoaS2CIniFewv7FXtwTerdKc1_4Z_szCZ39KT1JYRks_mY2cxvdmd-A_DKOqmDDi71ptGpDKVMFRr2tPBcBe2Fd02MtvhaHp_Iz9NiugPrckfjB1xe6dpRPamTxfztxc_-PQ74d-Rxor1FCcycRVdPCIqY4-iw3ICbaJkqKuXwZYT78c9MzlLMSuFlSQsCYjrk0VzTzR7czhFQl4Ly3y6ZrcjufxUk_Tey8pKpOroLd0aMyT4MSnEPdkJ7H24NVSf7B_Dne-SMJb4NNmuX5J0vcWfVsTiX08fZbdw_Hyi8e4a4lh18m3DOTnu_6CKJCTOtZ0v860R2W0YJmxR0RM27hhnWdr_DnJ0ZSi5kZ7NI9xR7Xdjuop9HfgY0oG_Yoc4fwuTocHJwnI6FGVInS7VKpc-aTHLZFEbIImukrjJj85KwgDLBIIjJlfGVC-gcZbbwCIOU0NYoZYPn-SPYbbs2PAHGlTXShYoycmVmuAmqaEJeWZ4HIYJLgK8_e-1G0nKqnTGv0XkhqdVRajVJrR6llsDrzTXnA2XHf1t_JGluWhLddjzQLX7U4-itJT5eVjpnbS4lLWS6snI0n66lCNL5BF6udaHG4UlrLqYN3a9lLSqi95Fa5Qk8HnRjc6u1biVQbWnN1rNsn2lnp5ECnFYzK82fXtvnM9jDt6RQuZTz57CLihVeIHxa2f047YDbT1O-H8fHXxKOGWI |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structural+insights+into+catalytical+capability+for+CPT11+hydrolysis+and+substrate+specificity+of+a+novel+marine+microbial+carboxylesterase%2C+E93&rft.jtitle=Frontiers+in+microbiology&rft.au=Li%2C+Yang&rft.au=Rong%2C+Zhen&rft.au=Li%2C+Zhengyang&rft.au=Cui%2C+Henglin&rft.date=2023-01-11&rft.issn=1664-302X&rft.eissn=1664-302X&rft.volume=13&rft.spage=1081094&rft_id=info:doi/10.3389%2Ffmicb.2022.1081094&rft_id=info%3Apmid%2F36756200&rft.externalDocID=36756200 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-302X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-302X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-302X&client=summon |